Serial Number
79206752
Owner
Laboratoire Francais Du Fractionnement et des Biotechnologies,Attorney
Monte L. Falcoff/Jessica S. SachsFiling Date
Dec 14, 2016
MABFC Trademark
Serial Number: 79206752 • Registration: 5415118
Trademark Classes
Owner Contact Info
3, avenue des Tropiques
91958 Courtaboeuf , FR
Entity Type: 99
Legal Representation
Correspondence Address
Monte L. Falcoff/Jessica S. Sachs Harness, Dickey & Pierce, P.L.C.
5445 Corporate Drive
Suite 200
Troy, MI 48098
UNITED STATES
Trademark Details
Filing Date
December 14, 2016
Registration Date
March 6, 2018
Published for Opposition
December 19, 2017
Cancellation Date
September 20, 2024
Goods & Services
Pharmaceutical products and preparations for the treatment of cancer, autoimmune disorders, inflammatory disorders, viral and bacterial infections, blood diseases; medicines for cancer, autoimmune disorders, inflammatory disorders, viral and bacterial infections, blood diseases; protein supplements; diagnostic kits consisting primarily of monoclonal antibodies and fragment crystallizable proteins, buffers, and reagents for use in disease testing
Scientific and technological services, namely, scientific research and analysis in the field of monoclonal antibodies and fragment crystallizable proteins; design and development of medical products, namely, pharmaceutical compositions of monoclonal antibodies and fragment crystallizable proteins; scientific study and research in the field of the prevention and the treatment of cancer, autoimmune disorders, inflammatory disorders, viral and bacterial infections, blood diseases; research and development in the field of the prevention and the treatment of cancer, autoimmune disorders, inflammatory disorders, viral and bacterial infections, blood diseases; cellular and molecular biological research; design and development of medical products, namely, pharmaceutical compositions of monoclonal antibodies and fragment crystallizable proteins; testing, inspection or research of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; consulting in the field of medical research; engineering; genetic engineering; platform technology, namely, protein expression platform for research and development of pharmaceuticals; platform technology, namely, protein expression platform for manufacturing protein-based therapeutics; medical and scientific research of recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; laboratory services in the field of monoclonal antibodies
